High Tumor Mutational Burden in Hepatocellular Carcinoma

Area of Science:

• Oncology
• Genetics
• Cancer Research

Background:

• Hepatocellular carcinoma (HCC) is a prevalent and deadly liver cancer.
• Tumor mutational burden (TMB) is an emerging biomarker for cancer prognosis and immunotherapy response.
• The role of TMB in HCC is not well-defined due to typically low TMB values in this cancer type.

Observation:

• A 72-year-old female presented with advanced, diffuse HCC.
• Genetic analysis revealed an exceptionally high TMB of 87 mutations per megabase, which is rare for HCC.
• The patient experienced rapid disease progression despite treatment with immunotherapy.

Findings:

• This case presents an outlier HCC with a significantly elevated TMB.
• The aggressive clinical course suggests a potential correlation between high TMB and poor prognosis in HCC.
• The patient's rapid decline limited the assessment of immunotherapy efficacy.

Implications:

• Further research into high TMB in HCC is crucial for understanding its impact on prognosis.
• Investigating TMB in outlier cases may refine patient stratification for immunotherapy.
• Understanding TMB's role could improve clinical decision-making and treatment strategies for HCC.